Bora Pharmaceutical Laboratories Inc. acquired CDMO Assets of JHL Biotech, Inc. for $100 million.

Bora Pharmaceutical Laboratories Inc. acquired CDMO Assets from JHL Biotech, Inc. for $100 million on May 10, 2022. Under the terms of transactions, Bora will initially invest $50 million in the acquisition.

Bora Pharmaceutical Laboratories Inc. completed the acquisition of CDMO Assets from JHL Biotech, Inc., Inc on May 10, 2022.